Refine
Has Fulltext
- yes (2)
Is part of the Bibliography
- yes (2)
Year of publication
- 2023 (2) (remove)
Document Type
- Journal article (1)
- Doctoral Thesis (1)
Language
- English (2)
Keywords
- 2n+3 (1)
- 9-borafluorene (1)
- Borane (1)
- DFT (1)
- Dodecaborane (1)
- RCC (1)
- Radikal <Chemie> (1)
- biomarker (1)
- closo-Borane (1)
- kidney cancer (1)
1. Bis(1-(4-tolyl)-carboran-2-yl)-(4-tolyl)-borane, a new bis(o-carboranyl)-(R)-borane 1 was synthesised by lithiation of the o-carboranyl precursor and subsequent salt metathesis reaction with (4-tolyl)BBr2. Cyclic voltammetry experiments on 1 show multiple distinct reduction events with a one-electron first reduction. In a selective reduction experiment the corresponding paramagnetic radical anion 1•− was isolated and characterized. Single-crystal structure analyses allow an in-depth comparison of 1, 1•−, their calculated geometries, and the S1 excited state of 1.
2. The choice of backbone linker for ortho-bis-(9-borafluorene)s has a great influence on the LUMO located at the boron centers and therefore the reactivity of the respective compounds. Herein, we report the room temperature rearrangement of 1,2-bis-(9-borafluorenyl-)-ortho-carborane, C2B10H10-1,2-[B(C12H8)]2 ([2a]) featuring o-carborane as the inorganic three-dimensional backbone and the synthesis of 1,2-bis-(9-borafluorenyl-)benzene, C6H4-1,2-[B(C12H8)]2 (2b) its phenylene analog. DFT calculations on the transition state for the rearrangement support an intramolecular C–H bond activation process via an SEAr-like mechanism in [2a], and predicted that the same rearrangement would take place in 2b, but at elevated temperatures, which indeed proved to be the case.
3. We synthesized 4 a julolidine-like pyrenyl-o-carborane, with pyrene substituted at the 2,7-positions on the HOMO/LUMO nodal plane, continuing our research. Using solid state molecular structures, photophysical data, cyclic voltammetry, DFT and TD-DFT calculations we compare o-carborane and the B(mes)2 (mes = 2,4,6-Me3C6H2) as acceptor groups and confirm the julolidine-like donor strength.
(1) Background: Clear cell renal cell carcinoma extending into the inferior vena cava (ccRCC\(^{IVC}\)) represents a clinical high-risk setting. However, there is substantial heterogeneity within this patient subgroup regarding survival outcomes. Previously, members of our group developed a microRNA(miR)-based risk classifier — containing miR-21-5p, miR-126-3p and miR-221-3p expression — which significantly predicted the cancer-specific survival (CSS) of ccRCC\(^{IVC}\) patients. (2) Methods: Examining a single-center cohort of tumor tissue from n = 56 patients with ccRCC\(^{IVC}\), we measured the expression levels of miR-21, miR-126, and miR-221 using qRT-PCR. The prognostic impact of clinicopathological parameters and miR expression were investigated via single-variable and multivariable Cox regression. Referring to the previously established risk classifier, we performed Kaplan–Meier analyses for single miR expression levels and the combined risk classifier. Cut-off values and weights within the risk classifier were taken from the previous study. (3) Results: miR-21 and miR-126 expression were significantly associated with lymphonodal status at the time of surgery, the development of metastasis during follow-up, and cancer-related death. In Kaplan–Meier analyses, miR-21 and miR-126 significantly impacted CSS in our cohort. Moreover, applying the miR-based risk classifier significantly stratified ccRCC\(^{IVC}\) according to CSS. (4) Conclusions: In our retrospective analysis, we successfully validated the miR-based risk classifier within an independent ccRCC\(^{IVC}\) cohort.